Analystreport

Milestone Pharmaceuticals (NASDAQ:MIST) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Milestone Pharmaceuticals Inc. - Common Shares  (MIST) 
Last milestone pharmaceuticals inc. - common shares earnings: 3/6 07:00 am Check Earnings Report